SE9801148D0 - New receptors - Google Patents
New receptorsInfo
- Publication number
- SE9801148D0 SE9801148D0 SE9801148A SE9801148A SE9801148D0 SE 9801148 D0 SE9801148 D0 SE 9801148D0 SE 9801148 A SE9801148 A SE 9801148A SE 9801148 A SE9801148 A SE 9801148A SE 9801148 D0 SE9801148 D0 SE 9801148D0
- Authority
- SE
- Sweden
- Prior art keywords
- vdrr
- polypeptides
- methods
- polypeptide
- novel
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 abstract 8
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 8
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 8
- 238000000034 method Methods 0.000 abstract 4
- 239000000126 substance Substances 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 239000013604 expression vector Substances 0.000 abstract 2
- 239000003446 ligand Substances 0.000 abstract 2
- 108020005497 Nuclear hormone receptor Proteins 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000006255 nuclear receptors Human genes 0.000 abstract 1
- 108020004017 nuclear receptors Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000019491 signal transduction Effects 0.000 abstract 1
- 102000009310 vitamin D receptors Human genes 0.000 abstract 1
- 108050000156 vitamin D receptors Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9801148A SE9801148D0 (sv) | 1997-10-14 | 1998-03-31 | New receptors |
CA002306453A CA2306453A1 (en) | 1997-10-14 | 1998-08-31 | Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
EP98941985A EP1023323A1 (en) | 1997-10-14 | 1998-08-31 | Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
US09/143,828 US7118885B2 (en) | 1997-10-14 | 1998-08-31 | Nucleic acid encoding vitamin D receptor related polypeptide |
JP2000515925A JP2001519441A (ja) | 1997-10-14 | 1998-08-31 | 新規ビタミンd受容体関連ポリペプチド、かかるポリペプチドをコードする核酸配列及びその使用 |
KR1020007004011A KR20010031120A (ko) | 1997-10-14 | 1998-08-31 | 신규한 비타민 디 수용체 연관된 폴리펩티드, 이를인코딩하는 핵산 서열 및 이의 용도 |
CNB988112264A CN1134452C (zh) | 1997-10-14 | 1998-08-31 | 新的维生素d受体相关多肽、编码其的核苷酸序列及其用途 |
AU90131/98A AU732079B2 (en) | 1997-10-14 | 1998-08-31 | Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
PCT/SE1998/001548 WO1999019354A1 (en) | 1997-10-14 | 1998-08-31 | Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
NZ504025A NZ504025A (en) | 1997-10-14 | 1998-08-31 | Vitamin D receptor related polypeptides (VDRR) and its use in treating inflammatory disease |
US11/369,263 US20060228778A1 (en) | 1997-10-14 | 2006-03-06 | Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9703745A SE9703745D0 (sv) | 1997-10-14 | 1997-10-14 | New receptors |
SE9801148A SE9801148D0 (sv) | 1997-10-14 | 1998-03-31 | New receptors |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9801148D0 true SE9801148D0 (sv) | 1998-03-31 |
Family
ID=26663102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9801148A SE9801148D0 (sv) | 1997-10-14 | 1998-03-31 | New receptors |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1023323A1 (xx) |
JP (1) | JP2001519441A (xx) |
KR (1) | KR20010031120A (xx) |
CN (1) | CN1134452C (xx) |
AU (1) | AU732079B2 (xx) |
CA (1) | CA2306453A1 (xx) |
NZ (1) | NZ504025A (xx) |
SE (1) | SE9801148D0 (xx) |
WO (1) | WO1999019354A1 (xx) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1044216A4 (en) * | 1997-12-12 | 2001-10-31 | Merck & Co Inc | DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEINS, nNR7 AND nNR7-1 |
AU2003200641B2 (en) * | 1998-01-09 | 2008-04-03 | The Salk Institute For Biological Studies | Novel Steroid-activated Nuclear Receptors and Uses therefor |
US6984773B1 (en) | 1998-01-09 | 2006-01-10 | The Salk Institute For Biological Studies | Transgenic mice expressing a human SXR receptor polypeptide |
US6756491B2 (en) | 1998-01-09 | 2004-06-29 | The Salk Institute For Biological Studies | Steroid-activated nuclear receptors and uses therefor |
US6911537B2 (en) * | 1998-01-09 | 2005-06-28 | The Salk Institute For Biological Studies | Xenobiotic compound modulated expression systems and uses therefor |
US7238491B1 (en) | 1998-03-27 | 2007-07-03 | Smithkline Beecham Corporation | Pregnane X receptor method |
EP1066320A4 (en) * | 1998-03-27 | 2005-03-16 | Glaxo Group Ltd | ORPHAN NUCLEAR RECEPTOR |
FR2801311B1 (fr) * | 1999-11-22 | 2005-08-26 | Centre Nat Rech Scient | Polypeptides derives du recepteur nucleaire de la vitamine d, et leurs utilisations notamment dans le cadre du criblage d'analogues de la vitamine d |
AU2006200258B2 (en) * | 1999-12-09 | 2009-04-09 | The Salk Institute For Biological Studies | Novel steroid-activated nuclear receptors and uses therefor |
US6514941B1 (en) | 1999-12-10 | 2003-02-04 | Campina Melkunie B.V. | Method of preparing a casein hydrolysate enriched in anti-hypertensive peptides |
US20040053866A1 (en) * | 2002-08-21 | 2004-03-18 | The Regents Of The University Of California | Tumor suppressor genes and their uses |
SE0400489D0 (sv) * | 2004-02-27 | 2004-02-27 | Biovitrum Ab | Therapeutic proteins |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989009223A1 (en) * | 1988-03-30 | 1989-10-05 | Arch Development Corporation | Dna binding proteins including androgen receptor |
EP0609240B1 (en) * | 1991-09-17 | 2002-04-03 | The Salk Institute For Biological Studies | Receptors of the thyroid/steroid hormone receptor superfamily |
US5756448A (en) * | 1992-02-26 | 1998-05-26 | The General Hospital Corporation | Constitute activator of retinoid (CAR) receptor polypeptides |
US6391847B1 (en) * | 1995-01-17 | 2002-05-21 | The Salk Institute For Biological Studies | Method, polypeptides, nucleotide sequence of XOR-6, a vitamin D-like receptor from xenopus |
AU5426596A (en) * | 1995-05-16 | 1996-11-29 | Salk Institute For Biological Studies, The | Modulators for new members of the steroid/thyroid superfamily of receptors |
-
1998
- 1998-03-31 SE SE9801148A patent/SE9801148D0/xx unknown
- 1998-08-31 CN CNB988112264A patent/CN1134452C/zh not_active Expired - Fee Related
- 1998-08-31 JP JP2000515925A patent/JP2001519441A/ja active Pending
- 1998-08-31 NZ NZ504025A patent/NZ504025A/xx unknown
- 1998-08-31 AU AU90131/98A patent/AU732079B2/en not_active Ceased
- 1998-08-31 CA CA002306453A patent/CA2306453A1/en not_active Abandoned
- 1998-08-31 EP EP98941985A patent/EP1023323A1/en not_active Withdrawn
- 1998-08-31 WO PCT/SE1998/001548 patent/WO1999019354A1/en not_active Application Discontinuation
- 1998-08-31 KR KR1020007004011A patent/KR20010031120A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1999019354A1 (en) | 1999-04-22 |
NZ504025A (en) | 2003-04-29 |
KR20010031120A (ko) | 2001-04-16 |
CN1134452C (zh) | 2004-01-14 |
CN1279689A (zh) | 2001-01-10 |
AU732079B2 (en) | 2001-04-12 |
JP2001519441A (ja) | 2001-10-23 |
CA2306453A1 (en) | 1999-04-22 |
AU9013198A (en) | 1999-05-03 |
WO1999019354A9 (en) | 1999-12-02 |
EP1023323A1 (en) | 2000-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Harrison et al. | Oxidation regulates the inflammatory properties of the murine S100 protein S100A8 | |
Skowyra et al. | Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex | |
Watterson et al. | Structural similarities between the Ca2+-dependent regulatory proteins of 3': 5'-cyclic nucleotide phosphodiesterase and actomyosin ATPase. | |
DE69232537D1 (de) | Rezeptoren der steroid/thyroid superfamilie von rezeptoren | |
Teichmann et al. | Human TATA-binding protein-related factor-2 (hTRF2) stably associates with hTFIIA in HeLa cells | |
Todorov et al. | Characterization of a cancer cachectic factor | |
LaRochelle et al. | PDGF-D, a new protease-activated growth factor | |
Reubi et al. | SST3-selective potent peptidic somatostatin receptor antagonists | |
Kurosaki et al. | Functional properties of nicotinic acetylcholine receptor subunits expressed in various combinations | |
Jacobsen et al. | Differential targeting of nicotinic acetylcholine receptors by novel αA-conotoxins | |
SE9801148D0 (sv) | New receptors | |
Tan et al. | Characterization of Recombinant Extracellular Domain of Human Interleukin-10 Receptor (∗) | |
ATE191503T1 (de) | Somatostatinrezeptoren | |
ATE352618T1 (de) | Rezeptor 5, der eine für den zelltod verantwortliche domäne enthält | |
PT101297A (pt) | Factores mitogenicos gliais, sua preparacao e utilizacao | |
HUP0105337A2 (hu) | Az immunválaszban szerepet játszó új polipeptidek | |
ATE106940T1 (de) | Für das polypeptid des t-zellantigenreceptors kodierende nukleinsäure. | |
Bernat et al. | Determination of the energetics governing the regulatory step in growth hormone-induced receptor homodimerization | |
PT973794E (pt) | Receptores de netrina | |
MXPA02008239A (es) | Gen humano de la esquizofrenia. | |
Okamoto et al. | Insulin-like growth factor-II/mannose 6-phosphate receptor is incapable of activating GTP-binding proteins in response to mannose 6-phosphate, but capable in response to insulin-like growth factor-II | |
DE69934903D1 (de) | Mitogene regulatoren | |
WO1994028132A3 (en) | Opioid receptors: compositions and methods | |
WO1994026891A3 (en) | Purified mammalian flt3 ligands and agonists and antagonists thereof | |
Sievert et al. | Peptide mapping of the [125I] Iodoazidoketanserin and [125I] 2-N-[(3′-iodo-4′-azidophenyl) propionyl] tetrabenazine binding sites for the synaptic vesicle monoamine transporter |